Funding round brings in $6M for back pain drug developer

08/22/2013 | MedCityNews.com

Semnur Pharmaceuticals secured $6 million toward a funding round targeted at $30 million. The firm will use the proceeds to further develop its injectable drug for lower back pain. The drug is expected to enter midstage trials late next year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ